Tender detail
Medicine rebate agreements for the active ingredients indacaterol and glycopyrronium bromide
Summary
The procurement concerns non-exclusive rebate agreements for medicines containing the active ingredients indacaterol and glycopyrronium bromide. Agreements may be concluded at any time under the open-house model during the period from 1 December 2026 to 30 November 2028. Medicines included in the BfArM list of paediatric medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.